位置:首页 > 蛋白库 > PP1R7_HUMAN
PP1R7_HUMAN
ID   PP1R7_HUMAN             Reviewed;         360 AA.
AC   Q15435; B4DFD4; B5MCY6; Q9UQE5; Q9UQE6; Q9Y6K4;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 195.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 7;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 22;
GN   Name=PPP1R7; Synonyms=SDS22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=7498485; DOI=10.1016/0014-5793(95)01180-m;
RA   Renouf S., Beullens M., Wera S., Van Eynde A., Sikela J., Stalmans W.,
RA   Bollen M.;
RT   "Molecular cloning of a human polypeptide related to yeast sds22, a
RT   regulator of protein phosphatase-1.";
RL   FEBS Lett. 375:75-78(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10231361; DOI=10.1046/j.1432-1327.1999.00344.x;
RA   Ceulemans H., Van Eynde A., Perez-Callejon E., Beullens M., Stalmans W.,
RA   Bollen M.;
RT   "Structure and splice products of the human gene encoding sds22, a putative
RT   mitotic regulator of protein phosphatase-1.";
RL   Eur. J. Biochem. 262:36-42(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH PPP1CA; PPP1CB AND PPP1CC ISOFORM 1, AND MUTAGENESIS OF
RP   ASP-148; PHE-170; GLU-192; PHE-214; ASP-280; GLU-300; TRP-302 AND TYR-327.
RX   PubMed=12226088; DOI=10.1074/jbc.m206838200;
RA   Ceulemans H., Vulsteke V., De Maeyer M., Tatchell K., Stalmans W.,
RA   Bollen M.;
RT   "Binding of the concave surface of the Sds22 superhelix to the alpha
RT   4/alpha 5/alpha 6-triangle of protein phosphatase-1.";
RL   J. Biol. Chem. 277:47331-47337(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24 AND SER-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; SER-27; SER-44 AND
RP   SER-47, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-24 AND SER-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-322, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-44 AND SER-47, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Regulatory subunit of protein phosphatase 1. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PPP1CA, PPP1CB and PPP1CC/PPP1G isoform 1.
CC       {ECO:0000269|PubMed:12226088}.
CC   -!- INTERACTION:
CC       Q15435; P62136: PPP1CA; NbExp=7; IntAct=EBI-1024281, EBI-357253;
CC       Q15435; P62140: PPP1CB; NbExp=10; IntAct=EBI-1024281, EBI-352350;
CC       Q15435; P36873: PPP1CC; NbExp=5; IntAct=EBI-1024281, EBI-356283;
CC       Q15435; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-1024281, EBI-739895;
CC       Q15435-3; P01112: HRAS; NbExp=3; IntAct=EBI-10695066, EBI-350145;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=sds22alpha1;
CC         IsoId=Q15435-1; Sequence=Displayed;
CC       Name=2; Synonyms=sds22alpha2;
CC         IsoId=Q15435-2; Sequence=VSP_019244;
CC       Name=3; Synonyms=sds22beta1;
CC         IsoId=Q15435-3; Sequence=VSP_019245, VSP_019246;
CC       Name=4; Synonyms=sds22beta2;
CC         IsoId=Q15435-4; Sequence=VSP_019244, VSP_019245, VSP_019246;
CC       Name=5;
CC         IsoId=Q15435-5; Sequence=VSP_055672, VSP_019245, VSP_019246;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:7498485}.
CC   -!- SIMILARITY: Belongs to the SDS22 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z50749; CAA90626.1; -; mRNA.
DR   EMBL; AF067136; AAD26610.1; -; Genomic_DNA.
DR   EMBL; AF067130; AAD26610.1; JOINED; Genomic_DNA.
DR   EMBL; AF067132; AAD26610.1; JOINED; Genomic_DNA.
DR   EMBL; AF067133; AAD26610.1; JOINED; Genomic_DNA.
DR   EMBL; AF067134; AAD26610.1; JOINED; Genomic_DNA.
DR   EMBL; AF067135; AAD26610.1; JOINED; Genomic_DNA.
DR   EMBL; AF067136; AAD26611.1; -; Genomic_DNA.
DR   EMBL; AF067130; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067132; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067134; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067135; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067133; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067131; AAD26611.1; JOINED; Genomic_DNA.
DR   EMBL; AF067134; AAD26612.1; -; Genomic_DNA.
DR   EMBL; AF067130; AAD26612.1; JOINED; Genomic_DNA.
DR   EMBL; AF067131; AAD26612.1; JOINED; Genomic_DNA.
DR   EMBL; AF067132; AAD26612.1; JOINED; Genomic_DNA.
DR   EMBL; AF067133; AAD26612.1; JOINED; Genomic_DNA.
DR   EMBL; AF067134; AAD26613.1; -; Genomic_DNA.
DR   EMBL; AF067132; AAD26613.1; JOINED; Genomic_DNA.
DR   EMBL; AF067130; AAD26613.1; JOINED; Genomic_DNA.
DR   EMBL; AF067133; AAD26613.1; JOINED; Genomic_DNA.
DR   EMBL; BT007296; AAP35960.1; -; mRNA.
DR   EMBL; BT020134; AAV38936.1; -; mRNA.
DR   EMBL; AK294043; BAG57395.1; -; mRNA.
DR   EMBL; AC005237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW71243.1; -; Genomic_DNA.
DR   EMBL; BC000910; AAH00910.1; -; mRNA.
DR   EMBL; BC012397; AAH12397.1; -; mRNA.
DR   EMBL; BC013001; AAH13001.1; -; mRNA.
DR   CCDS; CCDS2546.1; -. [Q15435-1]
DR   CCDS; CCDS63190.1; -. [Q15435-5]
DR   CCDS; CCDS63192.1; -. [Q15435-3]
DR   CCDS; CCDS63193.1; -. [Q15435-4]
DR   CCDS; CCDS63194.1; -. [Q15435-2]
DR   PIR; S68209; S68209.
DR   RefSeq; NP_001269338.1; NM_001282409.1. [Q15435-2]
DR   RefSeq; NP_001269339.1; NM_001282410.1. [Q15435-3]
DR   RefSeq; NP_001269340.1; NM_001282411.1. [Q15435-4]
DR   RefSeq; NP_001269341.1; NM_001282412.1.
DR   RefSeq; NP_001269342.1; NM_001282413.1.
DR   RefSeq; NP_001269343.1; NM_001282414.1. [Q15435-5]
DR   RefSeq; NP_002703.1; NM_002712.2. [Q15435-1]
DR   PDB; 6HKW; X-ray; 3.09 A; A/B/C/D/E=1-360.
DR   PDB; 6MKY; X-ray; 2.90 A; A/B=100-360.
DR   PDB; 6OBN; X-ray; 2.70 A; C/D=56-360.
DR   PDB; 6OBP; X-ray; 2.70 A; C=56-360.
DR   PDBsum; 6HKW; -.
DR   PDBsum; 6MKY; -.
DR   PDBsum; 6OBN; -.
DR   PDBsum; 6OBP; -.
DR   AlphaFoldDB; Q15435; -.
DR   SMR; Q15435; -.
DR   BioGRID; 111502; 77.
DR   DIP; DIP-1005N; -.
DR   IntAct; Q15435; 50.
DR   MINT; Q15435; -.
DR   STRING; 9606.ENSP00000234038; -.
DR   iPTMnet; Q15435; -.
DR   MetOSite; Q15435; -.
DR   PhosphoSitePlus; Q15435; -.
DR   BioMuta; PPP1R7; -.
DR   DMDM; 74762145; -.
DR   REPRODUCTION-2DPAGE; IPI00033600; -.
DR   EPD; Q15435; -.
DR   jPOST; Q15435; -.
DR   MassIVE; Q15435; -.
DR   MaxQB; Q15435; -.
DR   PaxDb; Q15435; -.
DR   PeptideAtlas; Q15435; -.
DR   PRIDE; Q15435; -.
DR   ProteomicsDB; 60591; -. [Q15435-1]
DR   ProteomicsDB; 60592; -. [Q15435-2]
DR   ProteomicsDB; 60593; -. [Q15435-3]
DR   ProteomicsDB; 60594; -. [Q15435-4]
DR   ProteomicsDB; 6128; -.
DR   Antibodypedia; 34547; 267 antibodies from 28 providers.
DR   DNASU; 5510; -.
DR   Ensembl; ENST00000234038.11; ENSP00000234038.6; ENSG00000115685.15. [Q15435-1]
DR   Ensembl; ENST00000272983.12; ENSP00000272983.8; ENSG00000115685.15. [Q15435-2]
DR   Ensembl; ENST00000401987.5; ENSP00000385466.1; ENSG00000115685.15. [Q15435-4]
DR   Ensembl; ENST00000402734.5; ENSP00000385012.1; ENSG00000115685.15. [Q15435-5]
DR   Ensembl; ENST00000406106.7; ENSP00000385022.3; ENSG00000115685.15. [Q15435-3]
DR   Ensembl; ENST00000407025.5; ENSP00000385657.1; ENSG00000115685.15. [Q15435-1]
DR   GeneID; 5510; -.
DR   KEGG; hsa:5510; -.
DR   MANE-Select; ENST00000234038.11; ENSP00000234038.6; NM_002712.3; NP_002703.1.
DR   UCSC; uc002was.5; human. [Q15435-1]
DR   CTD; 5510; -.
DR   DisGeNET; 5510; -.
DR   GeneCards; PPP1R7; -.
DR   HGNC; HGNC:9295; PPP1R7.
DR   HPA; ENSG00000115685; Low tissue specificity.
DR   MIM; 602877; gene.
DR   neXtProt; NX_Q15435; -.
DR   OpenTargets; ENSG00000115685; -.
DR   PharmGKB; PA33658; -.
DR   VEuPathDB; HostDB:ENSG00000115685; -.
DR   eggNOG; KOG0531; Eukaryota.
DR   GeneTree; ENSGT00940000158551; -.
DR   InParanoid; Q15435; -.
DR   OMA; YDNLIAH; -.
DR   PhylomeDB; Q15435; -.
DR   TreeFam; TF105538; -.
DR   PathwayCommons; Q15435; -.
DR   SignaLink; Q15435; -.
DR   BioGRID-ORCS; 5510; 662 hits in 1088 CRISPR screens.
DR   ChiTaRS; PPP1R7; human.
DR   GeneWiki; PPP1R7; -.
DR   GenomeRNAi; 5510; -.
DR   Pharos; Q15435; Tbio.
DR   PRO; PR:Q15435; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q15435; protein.
DR   Bgee; ENSG00000115685; Expressed in right testis and 203 other tissues.
DR   ExpressionAtlas; Q15435; baseline and differential.
DR   Genevisible; Q15435; HS.
DR   GO; GO:0005694; C:chromosome; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IBA:GO_Central.
DR   GO; GO:0030234; F:enzyme regulator activity; NAS:UniProtKB.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; TAS:ProtInc.
DR   GO; GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IMP:MGI.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR003603; U2A'_phosphoprotein32A_C.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SMART; SM00446; LRRcap; 1.
DR   PROSITE; PS51450; LRR; 12.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Leucine-rich repeat;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..360
FT                   /note="Protein phosphatase 1 regulatory subunit 7"
FT                   /id="PRO_0000239613"
FT   REPEAT          77..98
FT                   /note="LRR 1"
FT   REPEAT          99..120
FT                   /note="LRR 2"
FT   REPEAT          121..142
FT                   /note="LRR 3"
FT   REPEAT          143..164
FT                   /note="LRR 4"
FT   REPEAT          165..186
FT                   /note="LRR 5"
FT   REPEAT          187..208
FT                   /note="LRR 6"
FT   REPEAT          209..230
FT                   /note="LRR 7"
FT   REPEAT          231..252
FT                   /note="LRR 8"
FT   REPEAT          253..274
FT                   /note="LRR 9"
FT   REPEAT          275..296
FT                   /note="LRR 10"
FT   REPEAT          297..318
FT                   /note="LRR 11"
FT   DOMAIN          331..360
FT                   /note="LRRCT"
FT   REGION          1..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..15
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        16..38
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         24
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..60
FT                   /note="MAAERGAGQQQSQEMMEVDRRVESEESGDEEGKKHSSGIVADLSEQSLKDGE
FT                   ERGEEDPE -> M (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055672"
FT   VAR_SEQ         18..60
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_019244"
FT   VAR_SEQ         274..280
FT                   /note="NKLTMLD -> VQDSLTY (in isoform 3, isoform 4 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_019245"
FT   VAR_SEQ         281..360
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_019246"
FT   MUTAGEN         148
FT                   /note="D->V: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         170
FT                   /note="F->A: Severely impaired the binding of protein
FT                   phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         192
FT                   /note="E->A: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         214
FT                   /note="F->A: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         280
FT                   /note="D->A: Severely impairs the binding of protein
FT                   phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         300
FT                   /note="E->A: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         302
FT                   /note="W->A: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   MUTAGEN         327
FT                   /note="Y->A: Completely abolishes the interaction with
FT                   protein phosphatase 1."
FT                   /evidence="ECO:0000269|PubMed:12226088"
FT   TURN            59..62
FT                   /evidence="ECO:0007829|PDB:6HKW"
FT   HELIX           69..74
FT                   /evidence="ECO:0007829|PDB:6HKW"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:6HKW"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   HELIX           94..96
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          102..104
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          123..126
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          190..192
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   HELIX           311..317
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   HELIX           332..335
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   HELIX           339..346
FT                   /evidence="ECO:0007829|PDB:6OBN"
FT   STRAND          351..353
FT                   /evidence="ECO:0007829|PDB:6MKY"
SQ   SEQUENCE   360 AA;  41564 MW;  49BCCF675EAA94D1 CRC64;
     MAAERGAGQQ QSQEMMEVDR RVESEESGDE EGKKHSSGIV ADLSEQSLKD GEERGEEDPE
     EEHELPVDME TINLDRDAED VDLNHYRIGK IEGFEVLKKV KTLCLRQNLI KCIENLEELQ
     SLRELDLYDN QIKKIENLEA LTELEILDIS FNLLRNIEGV DKLTRLKKLF LVNNKISKIE
     NLSNLHQLQM LELGSNRIRA IENIDTLTNL ESLFLGKNKI TKLQNLDALT NLTVLSMQSN
     RLTKIEGLQN LVNLRELYLS HNGIEVIEGL ENNNKLTMLD IASNRIKKIE NISHLTELQE
     FWMNDNLLES WSDLDELKGA RSLETVYLER NPLQKDPQYR RKVMLALPSV RQIDATFVRF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024